These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

96 related articles for article (PubMed ID: 10880898)

  • 1. [Medical resources consumption of type 2 diabetics in France in 1998].
    Detournay B; Fagnani F; Pribil C; Eschwège E
    Diabetes Metab; 2000 May; 26(3):225-31. PubMed ID: 10880898
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Costs of long-term complications in type 2 diabetes patients in Germany. Results of the CODE-2 Study].
    Liebl A; Spannheimer A; Reitberger U; Görtz A
    Med Klin (Munich); 2002 Dec; 97(12):713-9. PubMed ID: 12491064
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Revealing the cost of Type II diabetes in Europe.
    Jönsson B;
    Diabetologia; 2002 Jul; 45(7):S5-12. PubMed ID: 12136405
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Epidemiology and costs of diabetes treated with insulin in France.
    Detournay B; Raccah D; Cadilhac M; Eschwège E
    Diabetes Metab; 2005 Jun; 31(3 Pt 2):3-18. PubMed ID: 16142041
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Prevalence of diabetes, antidiabetic treatment and chronic diabetic complications reported by general practitioners].
    Fabian W; Majkowska L; Stefański A; Moleda P
    Przegl Lek; 2005; 62(4):201-5. PubMed ID: 16229234
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Economic costs of diabetes in the U.S. In 2007.
    American Diabetes Association
    Diabetes Care; 2008 Mar; 31(3):596-615. PubMed ID: 18308683
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Epidemiology of complications and total treatment costs from diagnosis of Type 2 diabetes in Germany (ROSSO 4).
    Martin S; Schramm W; Schneider B; Neeser K; Weber C; Lodwig V; Heinemann L; Scherbaum WA; Kolb H
    Exp Clin Endocrinol Diabetes; 2007 Sep; 115(8):495-501. PubMed ID: 17853332
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Health economics analysis of diabetes is necessary. It facilitates decision-making and international comparison].
    Henriksson F; Agardh CD; Berne C; Bolinder J; Jönsson B
    Lakartidningen; 1999 Sep; 96(37):3915-6, 3919. PubMed ID: 10522101
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The SCOPE study: health-care consumption related to patients with chronic obstructive pulmonary disease in France.
    Detournay B; Pribil C; Fournier M; Housset B; Huchon G; Huas D; Godard P; Voinet C; Chanal I; Jourdanne C; Durand-Zaleski I;
    Value Health; 2004; 7(2):168-74. PubMed ID: 15164806
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Prevalence of diagnosed type 2 diabetes mellitus in the French general population: the INSTANT study.
    Bringer J; Fontaine P; Detournay B; Nachit-Ouinekh F; Brami G; Eschwege E
    Diabetes Metab; 2009 Feb; 35(1):25-31. PubMed ID: 19046913
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The cost of treating type 2 diabetes (CODEIRE).
    Nolan JJ; O'Halloran D; McKenna TJ; Firth R; Redmond S
    Ir Med J; 2006; 99(10):307-10. PubMed ID: 17274175
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Patient classification and analysis of risk profiles for type 2 diabetics as the main focus point in practice. Results of the TEMPO study].
    Lippmann-Grob B; Bierwirth RA; Kron P; Leinhos B; Funke K; Huptas M; Grüneberg M; Weich KW; Münscher C; Potthoff F
    Dtsch Med Wochenschr; 2004 Jan; 129(3):75-81. PubMed ID: 14724780
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Antidepressants consumption in the global population in France].
    Olié JP; Elomari F; Spadone C; Lépine JP
    Encephale; 2002; 28(5 Pt 1):411-7. PubMed ID: 12386542
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The obesity-driven rising costs of type 2 diabetes in Australia: projections from the Fremantle Diabetes Study.
    Davis WA; Knuiman MW; Hendrie D; Davis TM
    Intern Med J; 2006 Mar; 36(3):155-61. PubMed ID: 16503950
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Major complications have an impact on total annual medical cost of diabetes: results of a database analysis.
    Morsanutto A; Berto P; Lopatriello S; Gelisio R; Voinovich D; Cippo PP; Mantovani LG
    J Diabetes Complications; 2006; 20(3):163-9. PubMed ID: 16632236
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Costs of antihyperglycemic drugs and consumables and treatment satisfaction in patients with type 2 diabetes. Results of the health care research study LIVE-DE (long-acting insulin glargine compared with NPH insulin in Germany)].
    Hauner H; Kohlmann T; Landgraf W; Holle R; Pirk O; Scholten T
    Dtsch Med Wochenschr; 2009 Jun; 134(23):1207-13. PubMed ID: 19472091
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Juvenile obesity and comorbidity type 2 diabetes mellitus (T2 DM) in Germany: development and cost-of-illness analysis].
    Wolfenstetter SB
    Gesundheitswesen; 2006 Oct; 68(10):600-12. PubMed ID: 17099820
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Assessment of the budgetary impact of treatment guidelines in type II diabetes mellitus in France].
    Marissal JP; Sailly JC; Crainich D; Lebrun T
    Rev Epidemiol Sante Publique; 2005 Sep; 53 Spec No 1():1S67-78. PubMed ID: 16327742
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Resource use and costs of type 2 diabetes in Sweden - estimates from population-based register data.
    Ringborg A; Martinell M; Stålhammar J; Yin DD; Lindgren P
    Int J Clin Pract; 2008 May; 62(5):708-16. PubMed ID: 18355236
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Prevalence and treatment of diabetes in France: trends between 2000 and 2005.
    Kusnik-Joinville O; Weill A; Salanave B; Ricordeau P; Allemand H
    Diabetes Metab; 2008 Jun; 34(3):266-72. PubMed ID: 18524662
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.